| Description |
1 online resource (viii, 99 pages) : illustrations |
| Series |
Therapeutic strategies |
|
Therapeutic strategies.
|
| Contents |
Editors and Contributors; Chapter 1: Imaging of the right heart and pulmonary circulation; Chapter 2: Exercise testing and haemodynamics; Chapter 3: Epidemiology of pulmonary arterial hypertension; Chapter 4: Current treatment of PAH: prostanoids, phosphodiesterase-5 inhibitors and stimulators of soluble guanylate cyclase; Chapter 5: The future treatment of pulmonary hypertension; Chapter 6: Endothelin receptor antagonists; Chapter 7: Gene and stem cell therapy in pulmonary arterial hypertension; Abbreviations; Index |
| Summary |
Pulmonary arterial hypertension (PAH) is a rare condition; yet this very rarity can be a disadvantage when it comes to treatment, making PAH difficult to diagnose, and resulting in suboptimal patient care. Furthermore, the global burden of PAH remains poorly understood and largely underestimated, as PAH commonly presents as a comorbidity with such conditions as systemic sclerosis, COPD, idiopathic pulmonary fibrosis and left-heart dysfunction. However, in recent years there has been significant investment in developing new therapies for PAH, and treatment for this previously neglected disease |
| Bibliography |
Includes bibliographical references and index |
| Subject |
Pulmonary hypertension.
|
|
Pulmonary artery.
|
|
Hypertension, Pulmonary -- therapy
|
|
Hypertension, Pulmonary
|
|
Pulmonary Artery
|
|
MEDICAL -- Pulmonary & Thoracic Medicine.
|
|
Pulmonary artery
|
|
Pulmonary hypertension
|
| Form |
Electronic book
|
| Author |
Peacock, A. J.
|
|
Barberà , J. A
|
| ISBN |
9781846926105 |
|
1846926106 |
|
9781846920530 |
|
1846920531 |
|
